Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

About Tourette syndrome (TS) Tourette syndrome is a complex neurological condition characterized by involuntary tics. The Centers for Disease Control and Prevention (CDC) estimates that more than ...

Coprolalia is arguably the most stereotypical Tourette syndrome — but it only occurs in about 10% of cases, according to the U.S. Centers for Disease Control and Prevention. Dupree also lives ...

Pennsylvania Governor Josh Shapiro proposed legalizing recreational marijuana during his budget address on Tuesday. The ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

Low-quality information on social media may be contributing to a rise in teen mental illness. A new construct may help ...

Causes may include several movement disorders, such as Tourette syndrome and Parkinson’s disease. Involuntary head movements are often known as: Involuntary head twitching can be due to several ...

Researchers have identified specific gene variants that have significant impacts on brain development and are shared across ...